PUBLISHER: Grand View Research | PRODUCT CODE: 1571817
PUBLISHER: Grand View Research | PRODUCT CODE: 1571817
The global automated breast ultrasound market size is expected to reach USD 4.49 billion by 2030, expanding at a CAGR of 13.6%, according to a new report by Grand View Research, Inc. The rising incidence of this form of cancer, technological advancement, and various initiatives undertaken to raise awareness regarding cancer across the globe are expected to propel market growth.
Government, non-profit organizations, and various private companies are taking several initiatives to raise cancer awareness among women and men. The aim of these initiatives is to highlight the importance of cancer awareness and raise funds to support research on cancer treatment. For instance, the Estee Lauder Companies organized a breast cancer campaign in 2018 with an aim to inspire women suffering from cancer and to create awareness among people across the globe. This campaign was one of the largest corporate philanthropic initiative and was supported by the company's employees. Furthermore, this campaign raised around USD 79.0 million, of which more than USD 65.0 million was utilized in 260 medical research grants through the Breast Cancer Research Foundation (BCRF) and in research, medical service, and education.
Such initiatives are expected to boost the demand for various automated ultrasound techniques for the screening of breast cancer, thereby propelling market growth. In addition, increasing prevalence of cancer across the globe is also anticipated to boost the demand for automated ultrasound systems. For instance, as per the Canadian Cancer Society in 2019, breast cancer is the most common cancer among Canadian women. Moreover, favorable reimbursement policies for cancer diagnosis and treatment are also expected to spur market growth.
Hospitals are the largest end users of automated ultrasound systems and this trend is likely to continue over the course of the forecast period. Favorable initiatives by governments and non-profit organizations and introduction of technologically advanced imaging equipment have driven this segment. North America is one of the most prominent markets, owing to high incidence of the chronic disease and growing awareness among patients regarding early screening and diagnosis.